Literature DB >> 19779964

The mRNA and protein expression of A-kinase anchor proteins 13 in human colorectal cancer.

Jian-Kun Hu1, Ling Wang, Yuan Li, Kun Yang, Peng Zhang, Xin-Zu Chen, Rong Wang, Zong-Guang Zhou.   

Abstract

There was no literature reporting the relationship between AKAP13 and colorectal carcinoma. This study is aim to investigate the expression and role of AKAP13 in human colorectal cancers. This study investigated 94 pair-matched human colorectal cancers and adjacent normal mucosa, as well as 36 adenomas, of which mRNA expression of AKAP13 was detected by relative Quantitative-Real-Time RT-PCR and protein expression by immunohistochemical staining. AKAP13 gene was upregulated in colorectal cancer group by 2.259 times compared to control group without significant difference (P = 0.081), and no expression was detected in adenoma by RT-PCR. The positive expression rate of AKAP13 protein in colorectal carcinoma (52.3%) was significantly higher than those in adenoma (9.1%) and normal tissue (34.7%) (P = 0.006) by immunohistochemical staining. Either the mRNA or protein expressions of AKAP13 were correlated with histological types and differentiation grade (P < 0.05). Our results suggest AKAP13 protein may be related to the carcinogenesis of human colorectal cancer. However, more deeply and larger scale research are required to prove the correlation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779964     DOI: 10.1007/s10238-009-0065-x

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  28 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

Review 2.  AKAP signalling complexes: focal points in space and time.

Authors:  Wei Wong; John D Scott
Journal:  Nat Rev Mol Cell Biol       Date:  2004-12       Impact factor: 94.444

3.  Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals.

Authors:  Paola Sterpetti; Luca Marucci; Cinzia Candelaresi; Deniz Toksoz; Gianfranco Alpini; Laura Ugili; Gianluca Svegliati Baroni; Giampiero Macarri; Antonio Benedetti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-01       Impact factor: 4.052

4.  Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif.

Authors:  D W Carr; R E Stofko-Hahn; I D Fraser; S M Bishop; T S Acott; R G Brennan; J D Scott
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

5.  RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma.

Authors:  Chang-Chieh Wu; Rong-Yaun Shyu; Jung-Mao Chou; Shu-Wen Jao; Pei-Chieh Chao; Jung-Cheng Kang; Sheng-Tang Wu; Shiang-Long Huang; Shun-Yuan Jiang
Journal:  Eur J Cancer       Date:  2006-01-19       Impact factor: 9.162

6.  Rho GTPases are over-expressed in human tumors.

Authors:  G Fritz; I Just; B Kaina
Journal:  Int J Cancer       Date:  1999-05-31       Impact factor: 7.396

7.  RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation.

Authors:  Shiyou Chen; Michelle Crawford; Regina M Day; Victorino R Briones; Jennifer E Leader; Pedro A Jose; Robert J Lechleider
Journal:  J Biol Chem       Date:  2005-11-28       Impact factor: 5.157

8.  RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation.

Authors:  L Wei; W Zhou; J D Croissant; F E Johansen; R Prywes; A Balasubramanyam; R J Schwartz
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

9.  Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex.

Authors:  Dario Diviani; Liliane Abuin; Susanna Cotecchia; Laetitia Pansier
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

10.  Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniae.

Authors:  Tina Mygind; Svend Birkelund; Niels H Birkebaek; Lars Østergaard; Jørgen Skov Jensen; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2002-07-09       Impact factor: 3.605

View more
  5 in total

1.  Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis.

Authors:  Patamaporn Molee; Poom Adisakwattana; Onrapak Reamtong; Songsak Petmitr; Thaniya Sricharunrat; Nantana Suwandittakul; Urai Chaisri
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  AKAP13 Rho-GEF and PKD-binding domain deficient mice develop normally but have an abnormal response to β-adrenergic-induced cardiac hypertrophy.

Authors:  Matthew J Spindler; Brian T Burmeister; Yu Huang; Edward C Hsiao; Nathan Salomonis; Mark J Scott; Deepak Srivastava; Graeme K Carnegie; Bruce R Conklin
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

3.  Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.

Authors:  Cristiane Bentin Toaldo; Xanthippi Alexi; Karin Beelen; Marleen Kok; Michael Hauptmann; Maurice Jansen; Els Berns; Jacques Neefjes; Sabine Linn; Rob Michalides; Wilbert Zwart
Journal:  BMC Cancer       Date:  2015-08-14       Impact factor: 4.430

4.  Generation of metastatic melanoma specific antibodies by affinity purification.

Authors:  Birgit Schütz; Anita Koppensteiner; David Schörghofer; Katharina Kinslechner; Gerald Timelthaler; Robert Eferl; Markus Hengstschläger; Albert Missbichler; Harald Hundsberger; Mario Mikula
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

5.  Long Non-Coding RNA ZNF667-AS1 Knockdown Curbs Liver Metastasis in Acute Myeloid Leukemia by Regulating the microRNA-206/AKAP13 Axis.

Authors:  Nan Wang; Yanping Feng; Jinye Xie; Hui Han; Qian Dong; Weijia Wang
Journal:  Cancer Manag Res       Date:  2020-12-23       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.